Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Similar articles for PubMed (Select 16358358)

1.
3.

Mitochondrial DNA mutations in Alzheimer's disease.

Hutchin TP, Heath PR, Pearson RC, Sinclair AJ.

Biochem Biophys Res Commun. 1997 Dec 18;241(2):221-5.

PMID:
9425253
4.
5.
6.

Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?

Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozić S, Pandolfo M, Lamarche J, DiStefano L, Chang LJ.

J Neurochem. 1999 Feb;72(2):700-7.

PMID:
9930743
8.

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease.

Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD Jr.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4526-31.

9.
10.

Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.

Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P Jr.

J Alzheimers Dis. 2006 Jul;9(2):183-93. Review.

PMID:
16873965
11.
12.

Quantitative detection of the expression of mitochondrial cytochrome c oxidase subunits mRNA in the cerebral cortex after experimental traumatic brain injury.

Dai W, Cheng HL, Huang RQ, Zhuang Z, Shi JX.

Brain Res. 2009 Jan 28;1251:287-95. doi: 10.1016/j.brainres.2008.11.034. Epub 2008 Nov 21.

PMID:
19063873
13.

High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain.

Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF.

Hum Mol Genet. 2002 Jan 15;11(2):133-45.

14.

Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing.

Coon KD, Valla J, Szelinger S, Schneider LE, Niedzielko TL, Brown KM, Pearson JV, Halperin R, Dunckley T, Papassotiropoulos A, Caselli RJ, Reiman EM, Stephan DA.

Mitochondrion. 2006 Aug;6(4):194-210. Epub 2006 Jul 21.

PMID:
16920408
15.

Identification and characterization of OGG1 mutations in patients with Alzheimer's disease.

Mao G, Pan X, Zhu BB, Zhang Y, Yuan F, Huang J, Lovell MA, Lee MP, Markesbery WR, Li GM, Gu L.

Nucleic Acids Res. 2007;35(8):2759-66. Epub 2007 Apr 10.

16.

Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes.

Reddy PL, Shetty VT, Dutt D, York A, Dar S, Mundle SD, Allampallam K, Alvi S, Galili N, Saberwal GS, Anthwal S, Shaikh M, Suleman S, Kamal SY, Raza A.

Br J Haematol. 2002 Mar;116(3):564-75.

PMID:
11849212
17.

Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease.

Ito S, Ohta S, Nishimaki K, Kagawa Y, Soma R, Kuno SY, Komatsuzaki Y, Mizusawa H, Hayashi J.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2099-103.

18.

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.

Chandrasekaran K, Giordano T, Brady DR, Stoll J, Martin LJ, Rapoport SI.

Brain Res Mol Brain Res. 1994 Jul;24(1-4):336-40.

PMID:
7968373
19.

Cytochrome oxidase deficiency in Alzheimer's disease.

Parker WD Jr.

Ann N Y Acad Sci. 1991;640:59-64.

PMID:
1663716
20.

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.

Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G.

Neurobiol Aging. 2002 May-Jun;23(3):371-6.

PMID:
11959398
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk